Rifampin isoniazid: Difference between revisions
Jump to navigation
Jump to search
Created page with " __NOTOC__ {{Rifampin isoniazid}} {{CMG}}; {{AE}} {{chetan}} ==Overview== ==Category== ==US Brand Names== ==FDA Package Insert== '''Rifampin isoniazid description|Descri..." |
|||
| Line 7: | Line 7: | ||
==Category== | ==Category== | ||
Antimycobacterial | |||
==US Brand Names== | ==US Brand Names== | ||
Revision as of 02:21, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
Category
Antimycobacterial
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages